Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;9(5):563-582.
doi: 10.1159/000508568. Epub 2020 Jul 23.

The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017

Affiliations

The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017

Longfei Lin et al. Liver Cancer. 2020 Sep.

Abstract

Background: Liver cancer is one of the leading causes of cancer-related deaths worldwide. The primary causes of liver cancer include hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol consumption, nonalcoholic fatty liver disease, and other factors.

Aims: The objective of this study was to evaluate the global and sex-, age-, region-, country-, and etiology-related liver cancer burden, as well as the trends in liver cancer caused by different etiologies.

Methods: The causes of liver cancer from 1990 to 2017, including global, regional, and national liver cancer incidence, mortality, and etiology, were collected from the Global Burden of Disease study 2017, and the time-dependent change in the trends of liver cancer burden was evaluated by annual percentage change.

Results: The global liver cancer incidence and mortality have been increasing. There were 950,000 newly-diagnosed liver cancer cases and over 800,000 deaths in 2017, which is more than twice the numbers recorded in 1990. HBV and HCV are the major causes of liver cancer. HBV is the major risk factor of liver cancer in Asia, while HCV and alcohol abuse are the major risk factors in the high sociodemographic index and high human development index regions. The mean onset age and incidence of liver cancer with different etiologies have gradually increased in the past 30 years.

Conclusions: The global incidence is still rising and the causes have national, regional, or population specificities. More targeted prevention strategies must be developed for the different etiologic types in order to reduce liver cancer burden.

Keywords: Global Burden of Disease study; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Incidence and death.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest regarding the content of this paper.

Figures

Fig. 1
Fig. 1
Relative changes in ASDR (a) and ASIR (b) of liver cancer and five etiologies between 1990 and 2017 in different territories. ASDR, age-standardized death rate; ASIR, age-standardized incidence rate; HDI, human development index; LAU, liver cancer due to alcohol use; LHB, liver cancer due to hepatitis B; LHC, liver cancer due to hepatitis C; LNA, liver cancer due to nonalcoholic steatohepatitis; LOC, liver cancer due to other causes; SDI, sociodemographic index.
Fig. 2
Fig. 2
Global disease burden of liver cancer in 195 countries and territories. a ASDR of liver cancer in 2017. b ASIR of liver cancer in 2017. ASDR, age-standardized death rate; ASIR, age-standardized incidence rate.
Fig. 3
Fig. 3
Relative changes in ASDR (a) and ASIR (b) of liver cancer in 195 countries and territories between 1990 and 2017. ASDR, age-standardized death rate; ASIR, age-standardized incidence rate.
Fig. 4
Fig. 4
Proportion of five etiologies of liver cancer death cases (a) and incidence cases (b) in 2017. LAU, liver cancer due to alcohol use; LHB, liver cancer due to hepatitis B; LHC, liver cancer due to hepatitis C; LNA, liver cancer due to nonalcoholic steatohepatitis; LOC, liver cancer due to other causes.
Fig. 5
Fig. 5
a Age-standardized global deaths and incidence of liver cancer in 2017 by sex. b Age-specific global contributions to incidence and mortality of liver cancer in 2017. ASDR, age-standardized death rate; ASIR, age-standardized incidence rate; HDI, human development index; SDI, sociodemographic index.
Fig. 6
Fig. 6
Trends in global liver cancer from 1990 to 2017. ASDR of males (a), ASIR of males (b), ASDR of females (c), ASIR of females (d), and global average age of onset of liver cancer and five etiologies from 1990 to 2017 (e). *The APC is significantly different from zero at an alpha of 0.05. APC, annual percentage change; ASDR, age-standardized death rate; ASIR, age-standardized incidence rate; LAU, liver cancer due to alcohol use; LHB, liver cancer due to hepatitis B; LHC, liver cancer due to hepatitis C; LNA, liver cancer due to nonalcoholic steatohepatitis; LOC, liver cancer due to other causes.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68((6)):394–424. - PubMed
    1. National Cancer Institute Surveillance, Epidemiology, and End Results Program. https://seercancergov/statfacts/html/livibdhtml accessed on 09/2019.
    1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. CONCORD Working Group Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Mar;391((10125)):1023–75. - PMC - PubMed
    1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264–1273 e1261. - PMC - PubMed
    1. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010 Jun;51((6)):1972–8. - PubMed